TXN Stock Analysis: Texas Instruments | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 266.730m USD | 12M Return: 41.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.90B
EPS Trend: -74.5%
Qual. Beats: 1
Rev. Trend: -11.9%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Texas Instruments Incorporated (NASDAQ: TXN) is a Dallas-based semiconductor company founded in 1930 that designs, manufactures, and sells chips to electronics designers and manufacturers worldwide. It reports through two segments: Analog, which covers power management and signal chain products such as regulators, amplifiers, data converters, and interface devices, and Embedded Processing, which offers microcontrollers, connectivity and radar products, and applications processors. The portfolio also includes DLP imaging chips, calculators, and application-specific integrated circuits, sold into industrial, automotive, personal electronics, communications, and enterprise end markets.
The company reaches customers through a direct sales force, distributors, and its website, with geographic exposure spanning the United States, China, the rest of Asia, Europe, the Middle East, Africa, and Japan. Classified in the GICS Semiconductors sub-industry within Information Technology, TXN is a mega-cap constituent of the U.S. equity market and has been publicly traded since 1953.
- Industrial and automotive demand recovery lifts Analog segment margins
- China revenue exposure remains key risk amid semiconductor trade restrictions
- 300mm fab expansion drives capital returns trade-off versus near-term cash flow
| Net Income: 5.37b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 6.51 > 1.0 |
| NWC/Revenue: 58.03% < 20% (prev 66.03%; Δ -8.00% < -1%) |
| CFO/TA 0.23 > 3% & CFO 7.82b > Net Income 5.37b |
| Net Debt (9.63b) to EBITDA (8.82b): 1.09 < 3 |
| Current Ratio: 4.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (914.0m) vs 12m ago -0.22% < -2% |
| Gross Margin: 57.32% > 18% (prev 58.02%; Δ -0.70% > 0.5%) |
| Asset Turnover: 54.11% > 50% (prev 47.54%; Δ 6.57% > 0%) |
| Interest Coverage Ratio: 12.06 > 6 (EBIT TTM 6.70b / Interest Expense TTM 556.0m) |
| A: 0.31 (Total Current Assets 13.8b - Total Current Liabilities 3.10b) / Total Assets 34.4b |
| B: 1.53 (Retained Earnings 52.5b / Total Assets 34.4b) |
| C: 0.20 (EBIT TTM 6.70b / Avg Total Assets 34.1b) |
| D: 0.95 (Book Value of Equity 16.8b / Total Liabilities 17.6b) |
| Altman-Z'' = 9.34 = AAA |
| DSRI: 0.64 (Receivables 2.25b/3.06b, Revenue 18.4b/16.0b) |
| GMI: 1.01 (GM 58.02% / 57.32%) |
| AQI: 0.94 (AQ_t 0.25 / AQ_t-1 0.26) |
| SGI: 1.15 (Revenue 18.4b / 16.0b) |
| TATA: -0.07 (NI 5.37b - CFO 7.82b) / TA 34.4b) |
| Beneish M = -3.25 (Cap -4..+1) = AA |
As of July 08, 2026, the stock is trading at USD 293.30 with a total of 8,283,788 shares traded. Over the past week, the price has changed by +2.74%, over one month by +0.83%, over three months by +47.59% and over the past year by +41.29%.
Current recommended Stop Loss: 275.20 (which is 6.2% or 1.2 ATR below the current price).
Texas Instruments has received a consensus analysts rating of 3.70. Therefore, it is recommended to hold TXN.
- StrongBuy: 14
- Buy: 2
- Hold: 19
- Sell: 0
- StrongSell: 2
| Analysts Target Price | 298 | 1.6% |
P/E Trailing = 50.0137
P/E Forward = 39.2157
P/S = 14.4663
P/B = 16.1867
P/EG = 1.4241
Revenue TTM = 18.4b USD
EBIT TTM = 6.70b USD
EBITDA TTM = 8.82b USD
Long Term Debt = 12.9b USD (from longTermDebt, last quarter)
Short Term Debt = 1.15b USD (from shortTermDebt, last quarter)
Debt = 14.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 681.0m
Net Debt = 9.63b USD (calculated: Debt 14.7b - CCE 5.10b)
Enterprise Value = 276b USD (267b + Debt 14.7b - CCE 5.10b)
Interest Coverage Ratio = 12.06 (Ebit TTM 6.70b / Interest Expense TTM 556.0m)
EV/FCF = 74.27x (Enterprise Value 276b / FCF TTM 3.72b)
FCF Yield = 1.35% (FCF TTM 3.72b / Enterprise Value 276b)
FCF Margin = 20.18% (FCF TTM 3.72b / Revenue TTM 18.4b)
Net Margin = 29.11% (Net Income TTM 5.37b / Revenue TTM 18.4b)
Gross Margin = 57.32% ((Revenue TTM 18.4b - Cost of Revenue TTM 7.87b) / Revenue TTM)
Gross Margin QoQ = 58.01% (prev 55.89%)
Tobins Q-Ratio = 8.04 (Enterprise Value 276b / Total Assets 34.4b)
Interest Expense / Debt = 3.77% (Interest Expense 556.0m / Debt 14.7b)
Taxrate = 12.70% (781.0m / 6.15b)
NOPAT = 5.85b (EBIT 6.70b * (1 - 12.70%))
Current Ratio = 4.46 (Total Current Assets 13.8b / Total Current Liabilities 3.10b)
Debt / Equity = 0.88 (Debt 14.7b / totalStockholderEquity, last quarter 16.8b)
Debt / EBITDA = 1.09 (Net Debt 9.63b / EBITDA 8.82b)
Debt / FCF = 2.59 (Net Debt 9.63b / FCF TTM 3.72b)
Total Stockholder Equity = 16.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.75% (Net Income 5.37b / Total Assets 34.4b)
RoE = 32.49% (Net Income TTM 5.37b / Total Stockholder Equity 16.5b)
RoCE = 22.79% (EBIT 6.70b / Capital Employed (Equity 16.5b + L.T.Debt 12.9b))
RoIC = 18.56% (NOPAT 5.85b / Invested Capital 31.5b)
WACC = 11.01% (E(267b)/V(281b) * Re(11.44%) + D(14.7b)/V(281b) * Rd(3.77%) * (1-Tc(0.13)))
Discount Rate = 11.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -38.65 | Cagr: -0.05%
[DCF] Terminal Value 69.85% ; FCFF base≈2.81b ; Y1≈3.23b ; Y5≈4.75b
[DCF] Fair Price = 42.75 (EV 48.5b - Net Debt 9.63b = Equity 38.9b / Shares 910.1m; r=11.01% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -74.46 | EPS CAGR: -12.80% | SUE: 4.0 | # QB: 1
Revenue Correlation: -11.90 | Revenue CAGR: -0.83% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.92 | Chg30d=+0.00% | Revisions=+88% | Analysts=27
EPS next Quarter (2026-09-30): EPS=2.12 | Chg30d=+0.00% | Revisions=+88% | Analysts=27
EPS current Year (2026-12-31): EPS=7.68 | Chg30d=-0.05% | Revisions=+91% | GrowthEPS=+40.9% | GrowthRev=+18.8%
EPS next Year (2027-12-31): EPS=8.95 | Chg30d=+0.04% | Revisions=+90% | GrowthEPS=+16.5% | GrowthRev=+11.1%
[Analyst] Revisions Ratio: +97% (up=100, down=0)